Transtympanic Injections of N-acetylcysteine for the Prevention of Cisplatin-induced Ototoxicity

Evaluation of Audiometric Threshold Shift Criteria for Ototoxicity Monitoring

(2011) Dawn Konrad-Martin et al.   Journal of the American Academy of Audiology

Transtympanic Ringer's lactate application in the prevention of cisplatinum-induced ototoxicity in a chinchilla animal model

(2010) Raymundo Munguia et al.   OTOLARYNGOLOGY-HEAD AND NECK SURGERY

Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma

(2009) Howard M. Katzenstein et al.   CANCER

Permanent and transient effects of locally delivered n-acetyl cysteine in a guinea pig model of cochlear implantation

(2009) Hayden Eastwood et al.   HEARING RESEARCH

N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes

(2009) Rong Shi et al.   BMC Pharmacology & Toxicology

State-of-the-art mechanisms of intracochlear drug delivery

(2008) David A Borkholder   Current Opinion in Otolaryngology & Head and Neck Surgery

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility

(2008) Seetal Dodd et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Amifostine Protects Against Cisplatin-Induced Ototoxicity in Children With Average-Risk Medulloblastoma

(2008) Maryam Fouladi et al.   JOURNAL OF CLINICAL ONCOLOGY

Genetic variants associated with cisplatin-induced ototoxicity

(2008) Jan Oldenburg et al.   PHARMACOGENOMICS